Search
Nanomedicines for the treatment of inflammatory bowel diseases
Publication
Ali H,
Collnot E,
Windbergs M,
Lehr C
(2013)
European Journal of Nanomedicine, 5, 1, 10.1515/ejnm-2013-0004
European Journal of Nanomedicine, 5, 1, 10.1515/ejnm-2013-0004
From the structure of the skin barrier and dermal formulations to in vitro transport models for skin absorption
Publication
Windbergs M,
Hansen S,
Schroeter A,
Schaefer U,
Lehr C,
Bouwstra J
(2013)
Skin Pharmacology and Physiology, 26, 4-6, 317-330, 10.1159/000351936
Skin Pharmacology and Physiology, 26, 4-6, 317-330, 10.1159/000351936
Particle based vaccine formulations for transcutaneous immunization
Publication
Mittal A,
Raber A,
Lehr C,
Hansen S
(2013)
Human Vaccines and Immunotherapeutics, 9, 9, 1950-1955, 10.4161/hv.25217
Human Vaccines and Immunotherapeutics, 9, 9, 1950-1955, 10.4161/hv.25217
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease
Publication
Lautenschläger C,
Schmidt C,
Lehr C,
Fischer D,
Stallmach A
(2013)
European Journal of Pharmaceutics and Biopharmaceutics, 85, 3 PART A, 578-586, 10.1016/j.ejpb.2013.09.016, 24084650
European Journal of Pharmaceutics and Biopharmaceutics, 85, 3 PART A, 578-586, 10.1016/j.ejpb.2013.09.016, 24084650
Novel cell based in vitro models to study nanoparticle interaction with the inflamed intestinal mucosa
Publication
Leonard F
(2013)
Book
Book
Permutation Test (PT) and Tolerated Difference Test (TDT)
Publication
Gómez-Mantilla J,
Casabó V,
Schaefer U,
Lehr C
(2013)
International journal of pharmaceutics, 441, 1-2, 458-467, 10.1016/j.ijpharm.2012.11.008
International journal of pharmaceutics, 441, 1-2, 458-467, 10.1016/j.ijpharm.2012.11.008
Dissolution techniques for in vitro testing of dry powders for inhalation
Publication
May S,
Jensen B,
Wolkenhauer M,
Schneider M,
Lehr C
(2012)
Pharmaceutical research, 29, 8, 2157-2166, 10.1007/s11095-012-0744-2
Pharmaceutical research, 29, 8, 2157-2166, 10.1007/s11095-012-0744-2
Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions
Publication
Schaefer J,
Schulze C,
Marxer E,
Schaefer U,
Wohlleben W,
Bakowsky U,
Lehr C
(2012)
ACS Nano, 6, 6, 4603-4614, 10.1021/nn202657q
ACS Nano, 6, 6, 4603-4614, 10.1021/nn202657q
Nanoparticles for transcutaneous vaccination
Publication
Hansen S,
Lehr C
(2012)
Microbial Biotechnology, 5, 2, 156-167, 10.1111/j.1751-7915.2011.00284.x
Microbial Biotechnology, 5, 2, 156-167, 10.1111/j.1751-7915.2011.00284.x
Treatment of lung cancer via telomerase inhibition
Publication
Nafee N,
Schneider M,
Friebel K,
Dong M,
Schaefer U,
Mürdter T,
Lehr C
(2012)
European Journal of Pharmaceutics and Biopharmaceutics, 80, 3, 478-489, 10.1016/j.ejpb.2011.11.019
European Journal of Pharmaceutics and Biopharmaceutics, 80, 3, 478-489, 10.1016/j.ejpb.2011.11.019